Revelstoke Capital Partners
Overview
Revelstoke Capital Partners is a Denver-based private equity firm that invests in healthcare services, healthcare technology, and health and wellness companies to accelerate growth and drive improved outcomes.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vi Labs | May 2026 | Early Funding | Co-investor |
| NakedMD | Nov 2024 | Growth Equity | Lead |
For institutional investors. Book with your work email.
Key People
Dale Meyer
Co Founder Senior Advisor
Russell Cassella
Managing Partner
Tom Fagan
Managing Director, Portfolio Transformation Group
Adam Kirschman
Operating Partner
Albert Prast
Operating Partner
Andrew Welch
Partner
Anthony Hayes
Partner
Ashley McNamee
Partner, Responsible Investment
Gregory Pupo
Partner, Investor Relations
Michael Nutting
Partner, Debt Capital Markets
Blake Bennett
Partner, Chief Financial Officer & Chief Compliance Officer
Cy Barton-Dobenin
Principal
Michael Constantinides
Principal
Will Oliver
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Revelstoke Capital Partners based?
Revelstoke Capital Partners is headquartered in Denver, Colorado, United States.
When was Revelstoke Capital Partners founded?
Revelstoke Capital Partners was founded in 2013.
How many portfolio companies does Revelstoke Capital Partners have?
Revelstoke Capital Partners has 20 portfolio companies in Caplight's dataset.
What are some companies in Revelstoke Capital Partners's portfolio?
Portfolio companies visible on Caplight include Vi Labs, NakedMD.
What was Revelstoke Capital Partners's most recent investment shown here?
Revelstoke Capital Partners's most recent investment in this portfolio sample was in Vi Labs in 2026.
What sectors does Revelstoke Capital Partners focus on?
Revelstoke Capital Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Cybersecurity, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Consumer & Commerce, Healthcare & Life Sciences, Consumer & Commerce.
What company stages does Revelstoke Capital Partners focus on?
Revelstoke Capital Partners typically invests at the Late stage.
What is Revelstoke Capital Partners's AUM?
Revelstoke Capital Partners's assets under management are estimated between $5.8B and $6.8B.